𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study

✍ Scribed by D. Thaçi; J.-P. Ortonne; S. Chimenti; P.-D. Ghislain; P. Arenberger; K. Kragballe; J.-H. Saurat; A. Khemis; P. Sprøgel; H.-U. Esslinger; K. Unnebrink; H. Kupper

Book ID
108671207
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
500 KB
Volume
163
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of calcipotriol monotherapy a
Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study
✍ Ruzicka; Lorenz 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 848 KB

A clinical study was conducted to determine whether, in the topical treatment of psoriasis, a combination of calcipotriol and betamethasone valerate after previous treatment with calcipotriol alone was more effective than the continuation of the monotherapy with calcipotriol, especially in 'low resp

Efficacy and safety of a new combination
Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial
✍ L. Guenther; F. Cambazard; P.C.M. Van De Kerkhof; E. Snellman; K. Kragballe; A. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## Background: Calcipotriol and betamethasone dipropionate are both widely used, effective treatments for psoriasis. vitamin d analogues and topical corticosteroids have different mechanisms of action in the treatment of psoriasis. a new vehicle has been developed in order to contain both calcipotr

A multicentre, randomized, double-blind,
A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study
✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre